Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия
  • Бизнес Sort ascending
  • Functional Area
  • Дата
Длъжност Място Местоположение дивизия Бизнес Sort ascending Functional Area Дата
Medical Advisor Kazakhstan Kazakhstan International Innovative Medicines Research & Development Окт. 21, 2024
SSO Study Start-Up Manager Mapletree Business City (MBC) Singapore Development Innovative Medicines Research & Development Окт. 21, 2024
Study Start-Up Clinical Research Associate Mapletree Business City (MBC) Singapore Development Innovative Medicines Research & Development Окт. 21, 2024
Medical Safety Lead (Oncology) Hyderabad (Office) India Development Innovative Medicines Research & Development Окт. 21, 2024
(Senior) Medical Advisor (Radioligand Therapy) Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Research & Development Окт. 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Analytical Expert (Associate Director, Science & Technology) Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 10, 2024
Medical Safety Lead Hyderabad (Office) India Development Innovative Medicines Research & Development Окт. 10, 2024
Medical Science Liaison Immunology Field Force (England / Wales) United Kingdom International Innovative Medicines Research & Development Окт. 10, 2024
Patient Advocacy Manager Prague Czech Republic International Innovative Medicines Research & Development Окт. 10, 2024
Patient Advocacy & Medical Lead Prague Czech Republic International Innovative Medicines Research & Development Окт. 10, 2024
Medical Affairs Lead Specialty Warsaw Poland International Innovative Medicines Research & Development Окт. 11, 2024
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Септ. 02, 2024
Clinical Development Functional Head London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Септ. 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Септ. 03, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Септ. 05, 2024
Innovation Strategy Associate Director East Hanover USA Development Innovative Medicines Research & Development Септ. 05, 2024
Risk Management Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Септ. 06, 2024
Solution Design Associate Director Hyderabad (Office) India Development Innovative Medicines Research & Development Септ. 09, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Септ. 09, 2024
Clinical Document Management - Business Migrations Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Окт. 02, 2024
Strategy Director, Clinical Development Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 17, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentina Development Innovative Medicines Research & Development Авг. 15, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Септ. 03, 2024
Clinical Research Medical Advisor Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Септ. 06, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Окт. 16, 2024
Oncology MSL INSURGENTES Mexico International Innovative Medicines Research & Development Окт. 18, 2024
Patient Journey Partner Lead GTx INSURGENTES Mexico International Innovative Medicines Research & Development Окт. 21, 2024
Chef, Éducation médicale - Cancer du sein Montreal Canada International Innovative Medicines Research & Development Окт. 18, 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Окт. 23, 2024
Liaison en sciences médicales - Rheumatologie - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Окт. 25, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development Апр. 29, 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development Юни 02, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Септ. 04, 2024
RWE Lead H/F CDD 12 mois Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Research & Development Окт. 04, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Head, Clinical Development Business Solutions Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 10, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Окт. 14, 2024
Associate Director, Clinical Processes & Solutions Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Окт. 14, 2024
Head Clinical Development Business Solutions East Hanover USA Development Innovative Medicines Research & Development Окт. 18, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Medical Head Oncology Milano Italy International Innovative Medicines Research & Development Окт. 14, 2024
Clinical Research Associate Field Force (Italy) Italy Development Innovative Medicines Research & Development Окт. 16, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Май 27, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Септ. 03, 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Юли 02, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Юли 10, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Юли 18, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Юли 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България